Log in
Enquire now

List of Galapagos NV patents

List of Galapagos NV patents
List of Impulse Dynamics N.V. patents
List of Telekom Malaysia patents
List of Keiwa College patents
List of funding rounds for Coinspect
List of companies in Cherry Tree Investments's investment portfolio
Patents where
Current Assignee
Name
is
Galapagos NVGalapagos NV
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 7332337 Viral vectors having tissue tropism for T-lymphocytes, B- and mast cells

Patent 7332337 was granted and assigned to Galapagos NV on February, 2008 by the United States Patent and Trademark Office.

Galapagos NV
Galapagos NV
United States Patent and Trademark Office
United States Patent and Trademark Office
7332337
February 19, 2008
‌
US Patent 11339166 Compounds and pharmaceutical compositions thereof for the treatment of diseases

Patent 11339166 was granted and assigned to Galapagos NV on May, 2022 by the United States Patent and Trademark Office.

Galapagos NV
Galapagos NV
Galapagos NV
Galapagos NV
United States Patent and Trademark Office
United States Patent and Trademark Office
11339166
May 24, 2022
‌
US Patent 9415037 Compounds useful for the treatment of degenerative and inflammatory diseases

Patent 9415037 was granted and assigned to Galapagos NV on August, 2016 by the United States Patent and Trademark Office.

Galapagos NV
Galapagos NV
United States Patent and Trademark Office
United States Patent and Trademark Office
9415037
August 16, 2016
‌
US Patent 11564923 Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders

Patent 11564923 was granted and assigned to Galapagos NV on January, 2023 by the United States Patent and Trademark Office.

Galapagos NV
Galapagos NV
Galapagos NV
Galapagos NV
United States Patent and Trademark Office
United States Patent and Trademark Office
11564923
January 31, 2023
‌
US Patent 11072611 Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders

Patent 11072611 was granted and assigned to Galapagos NV on July, 2021 by the United States Patent and Trademark Office.

Galapagos NV
Galapagos NV
Galapagos NV
Galapagos NV
United States Patent and Trademark Office
United States Patent and Trademark Office
11072611
July 27, 2021
‌
US Patent 10526329 Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders

Patent 10526329 was granted and assigned to Galapagos NV on January, 2020 by the United States Patent and Trademark Office.

Galapagos NV
Galapagos NV
Galapagos NV
Galapagos NV
United States Patent and Trademark Office
United States Patent and Trademark Office
10526329
January 7, 2020
‌
US Patent 8993590 Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders

Patent 8993590 was granted and assigned to Galapagos NV on March, 2015 by the United States Patent and Trademark Office.

Galapagos NV
Galapagos NV
Galapagos NV
Galapagos NV
United States Patent and Trademark Office
United States Patent and Trademark Office
8993590
March 31, 2015
‌
US Patent 9249141 Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders

Patent 9249141 was granted and assigned to Galapagos NV on February, 2016 by the United States Patent and Trademark Office.

Galapagos NV
Galapagos NV
Galapagos NV
Galapagos NV
United States Patent and Trademark Office
United States Patent and Trademark Office
9249141
February 2, 2016
‌
US Patent 9505754 Compound useful for the treatment of degenerative and inflammatory diseases

Patent 9505754 was granted and assigned to Galapagos NV on November, 2016 by the United States Patent and Trademark Office.

Galapagos NV
Galapagos NV
United States Patent and Trademark Office
United States Patent and Trademark Office
9505754
November 29, 2016
‌
US Patent 10550100 5-[3-[piperzin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 4 and 5 inhibitors for treating E.G. osteoarthritis

Patent 10550100 was granted and assigned to Galapagos NV on February, 2020 by the United States Patent and Trademark Office.

Galapagos NV
Galapagos NV
United States Patent and Trademark Office
United States Patent and Trademark Office
10550100
February 4, 2020
‌
US Patent 11000528 Compound useful for the treatment of degenerative and inflammatory diseases

Patent 11000528 was granted and assigned to Galapagos NV on May, 2021 by the United States Patent and Trademark Office.

Galapagos NV
Galapagos NV
Galapagos NV
Galapagos NV
United States Patent and Trademark Office
United States Patent and Trademark Office
11000528
May 11, 2021
‌
US Patent 10508111 6-[5-amino-6-(2-ethoxyethoxy)-imidazo[4,5-B]pyridin-3-yl]-nicotinonitrile derivatives and their use as IRAK inhibitors

Patent 10508111 was granted and assigned to Galapagos NV on December, 2019 by the United States Patent and Trademark Office.

Galapagos NV
Galapagos NV
Galapagos NV
Galapagos NV
United States Patent and Trademark Office
United States Patent and Trademark Office
10508111
December 17, 2019
‌
US Patent 9062051 Compounds and pharmaceutical compositions thereof for the treatment of proliferative disorders

Patent 9062051 was granted and assigned to Galapagos NV on June, 2015 by the United States Patent and Trademark Office.

Galapagos NV
Galapagos NV
Galapagos NV
Galapagos NV
United States Patent and Trademark Office
United States Patent and Trademark Office
9062051
June 23, 2015
‌
US Patent 10328081 Compound useful for the treatment of degenerative and inflammatory diseases

Patent 10328081 was granted and assigned to Galapagos NV on June, 2019 by the United States Patent and Trademark Office.

Galapagos NV
Galapagos NV
Galapagos NV
Galapagos NV
United States Patent and Trademark Office
United States Patent and Trademark Office
10328081
June 25, 2019
‌
US Patent 9309244 Compound useful for the treatment of degenerative and inflammatory diseases

Patent 9309244 was granted and assigned to Galapagos NV on April, 2016 by the United States Patent and Trademark Office.

Galapagos NV
Galapagos NV
Galapagos NV
Galapagos NV
United States Patent and Trademark Office
United States Patent and Trademark Office
9309244
April 12, 2016
‌
US Patent 7915256 Triazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases

Patent 7915256 was granted and assigned to Galapagos NV on March, 2011 by the United States Patent and Trademark Office.

Galapagos NV
Galapagos NV
United States Patent and Trademark Office
United States Patent and Trademark Office
7915256
March 29, 2011
‌
US Patent 8999979 Compound useful for the treatment of degenerative and inflammatory diseases

Patent 8999979 was granted and assigned to Galapagos NV on April, 2015 by the United States Patent and Trademark Office.

Galapagos NV
Galapagos NV
Galapagos NV
Galapagos NV
United States Patent and Trademark Office
United States Patent and Trademark Office
8999979
April 7, 2015
‌
US Patent 8242274 Triazolopyridine kinase inhibitors useful for the treatment of degenerative and inflammatory diseases

Patent 8242274 was granted and assigned to Galapagos NV on August, 2012 by the United States Patent and Trademark Office.

Galapagos NV
Galapagos NV
United States Patent and Trademark Office
United States Patent and Trademark Office
8242274
August 14, 2012
‌
US Patent 9796719 Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders

Patent 9796719 was granted and assigned to Galapagos NV on October, 2017 by the United States Patent and Trademark Office.

Galapagos NV
Galapagos NV
Galapagos NV
Galapagos NV
United States Patent and Trademark Office
United States Patent and Trademark Office
9796719
October 24, 2017
‌
US Patent 11136325 Pyrrolopyrimidine and pyrrolopyridine derivatives

Patent 11136325 was granted and assigned to Galapagos NV on October, 2021 by the United States Patent and Trademark Office.

Galapagos NV
Galapagos NV
Galapagos NV
Galapagos NV
United States Patent and Trademark Office
United States Patent and Trademark Office
11136325
October 5, 2021
‌
US Patent 7977352 Triazolopyridine compounds useful for the treatment of degenerative and inflammatory diseases

Patent 7977352 was granted and assigned to Galapagos NV on July, 2011 by the United States Patent and Trademark Office.

Galapagos NV
Galapagos NV
United States Patent and Trademark Office
United States Patent and Trademark Office
7977352
July 12, 2011
‌
US Patent 10206907 Compounds useful for the treatment of degenerative and inflammatory diseases

Patent 10206907 was granted and assigned to Galapagos NV on February, 2019 by the United States Patent and Trademark Office.

Galapagos NV
Galapagos NV
Galapagos NV
Galapagos NV
United States Patent and Trademark Office
United States Patent and Trademark Office
10206907
February 19, 2019
‌
US Patent 8927543 Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders

Patent 8927543 was granted and assigned to Galapagos NV on January, 2015 by the United States Patent and Trademark Office.

Galapagos NV
Galapagos NV
Galapagos NV
Galapagos NV
United States Patent and Trademark Office
United States Patent and Trademark Office
8927543
January 6, 2015
‌
US Patent 9708312 Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders (GPR84 antagonists)

Patent 9708312 was granted and assigned to Galapagos NV on July, 2017 by the United States Patent and Trademark Office.

Galapagos NV
Galapagos NV
Galapagos NV
Galapagos NV
United States Patent and Trademark Office
United States Patent and Trademark Office
9708312
July 18, 2017
‌
US Patent 9255095 Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders

Patent 9255095 was granted and assigned to Galapagos NV on February, 2016 by the United States Patent and Trademark Office.

Galapagos NV
Galapagos NV
Galapagos NV
Galapagos NV
United States Patent and Trademark Office
United States Patent and Trademark Office
9255095
February 9, 2016
Results per page:
70 results
0 selected
70 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us